A decreased Level of Shp1 provides an additive survival advantage to the Ph plus Cells of CML Patients and may account for Resistance to Imatinib Treatment

被引：0

作者：

Esposito, Nicola ^{[1
,2
]}

Colavita, Irene ^{[1
,2
]}

Quarantelli, Fabrizio ^{[1
,2
]}

Izzo, Barbara ^{[1
,2
]}

Luciano, Luigia ^{[1
,2
]}

Del Vecchio, Luigi ^{[1
,2
]}

Hughes, Timothy ^{[3
]}

Radich, Jerald ^{[4
]}

Russo, Domenico ^{[5
]}

Soverini, Simona ^{[6
]}

Iacobucci, Ilaria ^{[6
]}

Martinelli, Giovanni ^{[6
]}

Saglio, Giuseppe ^{[7
]}

Melo, Junia ^{[3
]}

Ruoppolo, Margherita ^{[1
,2
]}

Kalebic, Thea

Pane, Fabrizio ^{[1
,2
]}

机构：

[1] Univ Naples Federico 2, CEINGE, Hematol Unit, Naples, Italy

[2] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Naples, Italy

[3] Inst Med & Vet Sci, Adelaide, SA 5000, Australia

[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[5] Univ Brescia, Chair Hematol, I-25121 Brescia, Italy

[6] Univ Bologna, Dept Hematol Oncol L & A Seragnoli, Bologna, Italy

[7] Univ Orbassano, Dept Cellular Biotechnol & Hematol, Turin, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1093 / 1093

页数：1